Grant will Help Develop More Powerful Disinfectants
News Feb 05, 2015
Temple Assistant Professor of Chemistry William Wuest has been awarded a $200,000 grant from the University City Science Center to develop the next generation of antibacterial cleansers and disinfectants.
Wuest and his collaborators have developed new antibiofilm compounds that have been found to be 100 times better in fighting drug-resistant bacteria than the active ingredients currently found in the most commonly used cleaning agents and disinfectants.
Biofilms are microorganisms, like bacteria, in which cells stick to each other on a surface. They are especially prevalent in hospital settings and can lead to chronic microbial infections such as MRSA.
Wuest said that his compounds are just as active against MRSA as they are against non-drug-resistant bacteria, which is especially important because commercial cleaners and disinfectants are losing their potency as bacteria become more resistant.
The grant is a part of the Science Center’s QED Proof-of-Concept Program, which aims to bridge the funding gap between research grants and commercial seed investment by providing funds for promising technologies in the healthcare industry. Half of the grant’s funding comes from the Science Center and the other half from the researcher’s institution.
“This funding is key in incorporating our compounds into new cleaners and disinfectants that can be used in real-world settings like hospitals, healthcare centers and nursing homes,” Wuest said. “We will use a portion of these funds to develop compounds to screen against resistant bacteria and evaluate their efficacy.”
Wuest’s project was one of four selected by the Science Center out of 68 submissions from nine universities in the Greater Philadelphia region. It is the fourth QED grant that Temple has received since the program began in 2009.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Molecule Prevents Common Cold Virus from Hijacking Human CellsNews
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.READ MORE
Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine AtomsNews
In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018